![]() |
市場調查報告書
商品編碼
2003604
獸醫內分泌市場規模、佔有率和成長分析:按產品類型、治療領域、動物類型、最終用戶和地區分類 - 產業預測,2026-2033 年Veterinary Endocrinology Market Size, Share, and Growth Analysis, By Product Category, By Therapeutic Area, By Animal Type, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球獸醫內分泌市場價值 4.7 億美元,預計將從 2025 年的 5.0243 億美元成長到 2033 年的 8.5684 億美元,在預測期(2026-2033 年)內以 6.9% 的複合年成長率成長。
全球獸醫內分泌市場是一個多元化的市場,涵蓋診斷、治療、醫療設備和服務,旨在解決伴侶動物和家畜的荷爾蒙失調問題。其成長主要受慢性內分泌疾病日益普遍的推動,而寵物「人性化」和診斷技術的進步進一步促進了這一成長。糖尿病和甲狀腺機能低下症等疾病對動物福利和獸醫醫療保健成本造成了重大影響。從有限的檢查室檢測轉向照護現場(PoC)解決方案,包括連續血糖監測和標靶荷爾蒙療法,正是這一發展趨勢的標誌。此外,技術整合正在簡化診斷流程並促進專業服務的發展,從而提高治療依從性。人工智慧驅動的診斷等創新技術提高了效率,並透過使獸醫院能夠更有效地處理複雜病例,為檢測開發商和獸醫教育機構拓展了市場機會。
全球獸醫內分泌市場促進因素
除了伴侶動物飼養趨勢之外,飼主日益重視改善寵物健康也顯著提升了對獸醫內分泌解決方案的需求。隨著越來越多的寵物飼主尋求定期獸醫檢查,內分泌疾病的識別和治療也變得越來越普遍,這增加了對專業診斷、荷爾蒙療法和持續監測服務的需求。由於人們越來越關注提高寵物的生活品質,獸醫正在實施更全面的診斷通訊協定和長期治療策略,從而推動了內分泌相關產品和服務在各類動物醫院、醫院和實驗室網路中的穩步普及。
全球獸醫內分泌市場面臨的限制因素
全球獸醫內分泌市場面臨嚴峻挑戰,主要原因是受過內分泌學訓練的獸醫短缺。這種短缺限制了臨床醫生識別複雜荷爾蒙失調的能力,也限制了他們有效利用先進診斷技術。因此,常見症狀可能被誤診為其他疾病,導致內分泌相關檢查和治療的轉診量下降。此外,專家的短缺也限制了全科獸醫的教育機會,進而減緩了創新診斷工具的普及,並限制了對專業檢測和設備的需求,尤其是在專家諮詢和培訓資源匱乏的地區。
全球獸醫內分泌市場趨勢
全球獸醫內分泌市場正呈現出精準診斷的顯著趨勢,獸醫診所擴大採用先進的診斷平台和檢測方法。這一轉變提高了內分泌疾病檢測的準確性,從而能夠更早地進行干預並制定更個性化的治療方案。臨床醫生更傾向於選擇能夠提供明確治療指南的高特異性檢測方法,這促進了實驗室與獸醫院之間的合作。此外,服務整合以及與技術供應商的合作正在簡化樣本檢體流程和報告流程。這些強調標準化通訊協定的進步,提高了寵物飼主和獸醫對診斷價值的認知,最終推動了對各種動物物種可靠內分泌檢測的需求。
Global Veterinary Endocrinology Market size was valued at USD 470.0 Million in 2024 and is poised to grow from USD 502.43 Million in 2025 to USD 856.84 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The global veterinary endocrinology market is a multifaceted landscape encompassing diagnostics, therapeutics, devices, and services aimed at addressing hormonal disorders in both companion animals and livestock. Its growth is primarily fueled by the increasing prevalence of chronic endocrine diseases, driven further by pet humanization and advancements in diagnostic capabilities. Conditions like diabetes mellitus and hypothyroidism significantly impact animal welfare and veterinary expenses. Transitioning from limited lab tests to point-of-care solutions, including continuous glucose monitors and targeted hormone therapies, exemplifies this evolution. Additionally, the integration of technology streamlines diagnosis and fosters specialized services, enhancing treatment adherence. Innovations such as AI-driven diagnostics improve efficiency, allowing practices to handle complex cases more effectively, expanding market opportunities for test developers and veterinary training providers.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Endocrinology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Veterinary Endocrinology Market Segments Analysis
Global veterinary endocrinology market is segmented by product category, therapeutic area, animal type, end-user and region. Based on product category, the market is segmented into Diagnostic Kits, Therapeutic Drugs and Lab-based Instruments. Based on therapeutic area, the market is segmented into Thyroid Disorders, Hyperadrenocorticism, Diabetes Mellitus Management and Addison's Disease. Based on animal type, the market is segmented into Companion Animals and Livestock. Based on end-user, the market is segmented into Veterinary Hospitals, Diagnostic & Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Veterinary Endocrinology Market
The growing trend of companion animal ownership, coupled with the increased commitment from caregivers to enhance their pets' healthcare, has significantly boosted the demand for veterinary endocrinology solutions. As more pet owners seek regular veterinary check-ups, the identification and management of endocrine disorders have become more prevalent, driving the need for specialized diagnostics, hormonal therapies, and ongoing monitoring services. With a heightened focus on improving the quality of life for pets, veterinarians are implementing more thorough diagnostic protocols and long-term treatment strategies, resulting in a consistent uptake of endocrinology products and services across various veterinary practices, hospitals, and laboratory networks.
Restraints in the Global Veterinary Endocrinology Market
The Global Veterinary Endocrinology market faces significant challenges due to the insufficient number of veterinarians trained in endocrinology. This shortage restricts the ability of clinicians to identify intricate hormonal disorders and utilize advanced diagnostic procedures effectively. As a result, common symptoms may be misattributed to other ailments, leading to a decrease in referrals for endocrinology-related testing and treatment. Furthermore, the lack of specialists limits the educational opportunities for general practitioners, which in turn delays the adoption of innovative diagnostic tools and restricts the demand for specialized assays and devices, particularly in areas with limited access to expert consultation and training resources.
Market Trends of the Global Veterinary Endocrinology Market
The Global Veterinary Endocrinology market is witnessing a significant trend towards the adoption of precision diagnostics, as veterinary practices increasingly implement advanced diagnostic platforms and assays. This shift enhances the detection of endocrine disorders, allowing for earlier interventions and more personalized treatment plans. Clinicians are favoring tests that provide higher specificity and clearer treatment pathways, which encourages collaboration between laboratories and animal health clinics. Additionally, the consolidation of services and partnerships with technology providers is streamlining sample workflows and reporting processes. With an emphasis on standardized protocols, these developments are elevating the perceived diagnostic value among pet owners and practitioners, ultimately driving demand for reliable endocrinology testing across diverse animal species.